scispace - formally typeset
M

Mengjia Song

Researcher at Sun Yat-sen University

Publications -  12
Citations -  634

Mengjia Song is an academic researcher from Sun Yat-sen University. The author has contributed to research in topics: Tumor microenvironment & Medicine. The author has an hindex of 6, co-authored 9 publications receiving 142 citations. Previous affiliations of Mengjia Song include Zhengzhou University.

Papers
More filters
Journal ArticleDOI

Roles of IFN-γ in tumor progression and regression: a review.

TL;DR: The current knowledge concerning the roles of IFN-γ in the TME as a part of the complex immune response to cancer is discussed and the importance of identifying IFn-γ responsive patients to improve their sensitivity to immuno-therapies is highlighted.
Journal ArticleDOI

Cancer‐Associated Fibroblast‐Mediated Cellular Crosstalk Supports Hepatocellular Carcinoma Progression

TL;DR: In this paper, the authors investigated the cellular crosstalk among CAFs, tumor cells, and tumor-associated neutrophils (TANs) during different stages of HCC pathogenesis.
Journal ArticleDOI

Low-Dose IFNγ Induces Tumor Cell Stemness in Tumor Microenvironment of Non–Small Cell Lung Cancer

TL;DR: In this paper, the authors reveal a dose-dependent effect of IFNγ in inducing tumor stemness to accelerate cancer progression in patients with a variety of cancer types, and elucidate the distinct molecular mechanisms activated by the inflammatory cytokine in a dosedependent manner.
Journal ArticleDOI

PUMA mediates ER stress-induced apoptosis in portal hypertensive gastropathy

TL;DR: Results indicate that PUMA mediates ER stress-induced mucosal epithelial apoptosis through the mitochondrial apoptotic pathway in PHG, and thatPUMA is a potentially therapeutic target for PHG.
Journal ArticleDOI

Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma.

TL;DR: The Galectin-3-β-catenin-IGFBP3/vimentin signalling cascade was determined as a central mechanism controlling HCC metastasis, providing possible biomarkers for predicating vascular metastasis and sorafenib resistance, as well as potential therapeutic targets for the treatment of HCC patients.